A UCLA team has developed an easy-to-use "risk calculator" that helps predict heart failure patients' chances of survival for up to five years and assists doctors in determining whether more or less aggressive treatment is appropriate. ...
HealthDay Reporter Latest Heart News Fitness in Teen Years Guards Against Heart Trouble Hispanic Women Unaware of Heart Disease Risks Tretten Approved for Genetic Clotting Disorder 'Stress Gene' Might Raise Odds for Heart Attack Warfarin ...
Sorin, a medical device company, has received CE Mark approval for its Intensia family of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) devices. The Intensia family includes single-chamber ...
Tags: medical device, CRT-D Devices
Approximately one year after the company landed FDA approval for its Ventricular Assist System, the company is boasting significant surge in revenue. In early morning trading on November 7, the company's shares increased by 15%. In total, ...
US-based CardioKinetix has announced the successful treatment of first two Chinese heart failure patients with its Parachute ventricular partitioning device, a minimally invasive treatment for patients with heart failure caused by damage to ...
Tags: CardioKinetix, Partitioning Device
ResMed, a developer of medical equipment for respiratory disorders, has enrolled 1,325 patients in SERVE-HF, an international, randomized study designed to determine sleep-disordered breathing in heart failure patients. The study will ...
Tags: ResMed, Serve-HF Study
Biotronik has unveiled the results from the IN-TIME study, a first randomized, controlled trial designed to assess the influence of Biotronik Home Monitoring on all-cause mortality in heart failure patients at the ESC (European Society of ...
CardioKinetix has announced the first successful procedure in four cardiac patients with its new catheter-based Parachute ventricular partitioning device in Kuala Lumpur, Malaysia. The new Parachute device is a new minimally invasive ...
Medtronic, a US-based manufacturer of implantable heart-rhythm devices, has acquired Cardiocom, a disease-management and patient-monitoring firm, in a $200m all-cash deal. Cardiocom is a manufacturer of glucose monitors and weight scales ...
Tags: Medtronic, heart-rhythm devices
Medtronic's study has demonstrated that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing with a cardiac resynchronization therapy (CRT) device, significantly improves heart failure symptoms and quality of ...
Tags: CRT Device, Heart Failure Symptoms
US based medical technology company Medtronic has introduced CardioGuide implant system in the US and Canada. The real-time navigation system is designed for determining the real-time location to place left-ventricular (LV) electrode lead ...
Medtronic has obtained CE mark certification from the European Union for its Attain Performa portfolio of quadripolar leads. The quadripolar leads are compatible with the company's Viva/Brava Quad cardiac resynchronization therapy ...
Tags: Medtronic, CE mark certification, Attain Performa portfolio
CircuLite has obtained conditional approval from the US Food and Drug Administration (FDA) for its Synergy Circulatory Support System, designed for reversing the symptoms of heart failure in ambulatory chronic heart failure patients. The ...
Tags: CircuLite, FDA Conditional Approval, Micro-Blood Pump Device
Medtronic has completed enrolling the first patient in MIRACLE EF clinical trial, designed to evaluate the effectiveness of its Consulta cardiac resynchronization therapy-pacemaker (CRT-P) in treating symptomatic heart failure patients with ...
Tags: Medtronic, MIRACLE EF, trial, CRT-P
If you think leaving the hospital means you're home for good, think again. About twenty percent of heart attack and pneumonia patients, and a quarter of heart failure patients, find themselves back in the hospital within 30 days, according ...
Tags: hospital, Medicare, Medicaid Services, hospital safety